The incidence of orofacial cancer has risen by 30-40% in the past 10 years in the UK. The epidemiology statistics have also revealed an increased number of cases in younger individuals and women. The presenting signs and symptoms of orofacial cancer are highly variable and can mimic benign conditions. However, an understanding of the presentation of malignant and non-malignant conditions is essential and can be key in influencing the need for “routine” or “urgent suspected cancer” referral. Efficient and appropriate is crucial for patients with suspicious orofacial lesions since the 5-year survival and outcome of these forms of cancer remain poor due to late detection.
Following completion of this programme viewers will:-
- Have an appreciation of the epidemiology of orofacial cancer in the UK
- Have knowledge of the presenting features of malignant and non-malignant orofacial conditions
- Have an appreciation of the methods of referral for patients with suspicious orofacial lesions
- Gain an assessment of their ability to detect orofacial cancer by use of a self assessed interactive quiz
This talk satisfies the GDC’s learning outcome:
- C – Maintenance and development of knowledge and skill within your field of practice
Professor Mike Lewis PhD, FDSRCPS, FRCPath, FDSRCS(Ed), FDSRCS(Eng), FFGDP(UK), FHEA
Professor Mike Lewis is Dean of the School of Dentistry, Cardiff University and Divisional Director for Dental Services, Cardiff & Vale University Health Board. He is an honorary consultant in Oral Medicine and has published over 200 scientific articles in the field of Oral Medicine. He is first author of the highly successful BDJ Clinical Guide to Oral Medicine 3rd edition and the Colour Handbook of Oral Medicine 2nd edition. He has delivered more than 450 postgraduate lectures worldwide. In addition, Professor Lewis has served as President of the British Society for Oral Medicine and is the immediate past Dean of the Dental Faculty of the Royal College of Physicians and Surgeons of Glasgow. He has previously acted as the representative for Dentistry on the Advisory Council for Misuse of Drugs (Home Office) and the Scientific Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (Department of Health).